4//SEC Filing
BRYCE RICHARD PAUL 4
Accession 0001209191-21-012523
CIK 0001401667other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 6:22 PM ET
Size
8.0 KB
Accession
0001209191-21-012523
Insider Transaction Report
Form 4
BRYCE RICHARD PAUL
SR VP, CLINICAL RESEARCH & DEV
Transactions
- Award
COMMON STOCK
2021-02-17+52,846→ 122,510 total - Award
STOCK OPTION (RIGHT TO BUY)
2021-02-17+74,341→ 74,341 totalExercise: $12.02Exp: 2031-02-16→ COMMON STOCK (74,341 underlying)
Footnotes (2)
- [F1]Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to (i) one-third (1/3) of the Restricted Stock Units on the first anniversary of of the commencement date of January 1, 2021 (the "Vesting Commencement Date") and (ii) one-sixth (1/6th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.
- [F2]Subject to the Optionee's continued service with the Company through the applicable vesting date, the Option shall vest and become exercisable with respect to (i) one-third (1/3) of the Shares (as defined in the Plan) underlying the Option on the first anniversary of January 1, 2021 (the "Vesting Commencement Date")and (ii) one-sixth (1/6th) of the Shares subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023, and January 1, 2024.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001553037
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 6:22 PM ET
- Size
- 8.0 KB